statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 PR Newswire PLYMOUTH MEETING...

HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024

HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT...

HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST

HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL...

HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME

Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eight research firms that are presently covering the...

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $41.00 Average Target Price from Brokerages

HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE PR Newswire PLYMOUTH...

HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY  Get Free Report) insider Jeffrey Dierks sold 11,979 shares of the firms stock in a transaction dated Friday, March 15th. The shares were...

Jeffrey Dierks Sells 11,979 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock

Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares

Exchange Traded Concepts LLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY  Free Report) by 0.8% during the fourth quarter, according to the company in its most recent...

Exchange Traded Concepts LLC Purchases 328 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

HRMY's total volume now sits at 1.2M. The +1.95% price change was insignificant, leaving IBM's price at $31.97...

The volume for Harmony Biosciences Holdings stock increased for one day, resulting in a record-breaking daily growth of 211% of the 65-Day Volume Moving Average

In trading on Friday, shares of Harmony Biosciences Holdings Inc (HRMY) crossed above their 200 day moving average of 31.98, changing hands as high as 32.06 per share. Harmony Biosciences...

Harmony Biosciences Holdings Breaks Above 200-Day Moving Average - Bullish for HRMY

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Volume	425,156.00
52-Wk High	$39.27
52-Wk Low	$18.61

HRMY Harmony Biosciences Holdings Inc

About

Feed

News

Sentiment

Earnings

Fundamentals